Skip to main content
Clinical Trials/NCT03402672
NCT03402672CompletedNot Applicable

A Web-based E-health Application for Active Illicit Opioid Users Providing Information About Overdose and Infection Risk Factors and Encouraging HCV/HIV Testing and Medication Assisted Treatment Seeking

University of Cincinnati1 site in 1 country24 target enrollmentStarted: November 8, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)

Study Overview

Brief Summary

The purpose of this research study is to:

  1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention
  2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies.
  3. assess the proportion of participants who accept a list of local treatment providers
  4. test the impact of AWAITS on interest in being tested for HCV/HIV.

Detailed Description

The pre-post study of AWAITS will: 1) assess the acceptability of AWAITS as measured by participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest in being tested for HCV/HIV.

The acceptability of AWAITS will be assessed with a feedback form which includes questions about how helpful the intervention was (scale of 1-4), what the patient liked most and least about the intervention, and any suggestions for improving it. The average (and standard deviation) for the rated helpfulness of the intervention will be derived and the qualitative data about what they liked most and least about the intervention and suggestions for improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list of local MAT treatment providers will be calculated.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •At least 18 years of age
  • •Not enrolled in MAT per self-report
  • •Self-reports illicit opioid use

Exclusion Criteria

  • •Does not acknowledge reviewing "Information Sheet for Research" within REDCap

Arms & Interventions

AWAITS

Experimental

Participants who meet criteria will receive the AWAITS self-administered, e-health application intervention.

Intervention: self-administered, e-health application (Other)

Outcomes

Primary Outcomes

3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)

Time Frame: Day 1

To test the impact of AWAITS on knowledge about opioid overdose

Secondary Outcomes

  • Feedback on AWAITS(Day 1)
  • Acceptance of list of MAT providers(Day 1)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Theresa Winhusen, PhD

Principal Investigator

University of Cincinnati

Study Sites (1)

Loading locations...

Similar Trials